Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Connecticut, United States
Disclosure information not submitted.
5E-02 - Risk of Diabetes in People Living with HIV Associated with Remaining on a TDF-containing Antiretroviral Regimen or Switching to a TAF-containing Regimen or Another Regimen Without Tenofovir
Tuesday, August 26, 20258:45 AM - 9:00 AM ET
6E-05 - Effect-based modeling of individualized treatment effects to predict benefit-harm balance: example using immune checkpoint inhibitors
Tuesday, August 26, 20252:30 PM - 2:45 PM ET
